Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis

Elizabeth M. Cameron, Sade Spencer, Jonathan Lazarini, Christopher T. Harp, E. Sally Ward, Mark Burgoon, Gregory P. Owens, Michael K. Racke, Jeffrey L. Bennett, Elliot Frohman, Nancy L Monson

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

We identified a unique antibody gene mutation pattern (i.e. "signature") in cerebrospinal fluid (CSF) B cells from multiple sclerosis (MS) patients not present in control populations. Prevalence of the signature in CSF B cells of patients at risk to develop MS predicted conversion to MS with 91% accuracy in a small cohort of clinically isolated syndrome patients. If confirmed, signature prevalence would be a novel genetic diagnostic tool candidate for patients with early demyelinating disease of the central nervous system.

Original languageEnglish (US)
Pages (from-to)123-130
Number of pages8
JournalJournal of Neuroimmunology
Volume213
Issue number1-2
DOIs
StatePublished - Aug 18 2009

Fingerprint

Multiple Sclerosis
Antibodies
Genes
Cerebrospinal Fluid
B-Lymphocytes
Demyelinating Diseases
Central Nervous System
Mutation
Population

Keywords

  • Antibodies
  • B lymphocytes
  • Gene rearrangement
  • Multiple sclerosis
  • Mutational signature

ASJC Scopus subject areas

  • Immunology
  • Clinical Neurology
  • Immunology and Allergy
  • Neurology

Cite this

Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis. / Cameron, Elizabeth M.; Spencer, Sade; Lazarini, Jonathan; Harp, Christopher T.; Ward, E. Sally; Burgoon, Mark; Owens, Gregory P.; Racke, Michael K.; Bennett, Jeffrey L.; Frohman, Elliot; Monson, Nancy L.

In: Journal of Neuroimmunology, Vol. 213, No. 1-2, 18.08.2009, p. 123-130.

Research output: Contribution to journalArticle

Cameron, EM, Spencer, S, Lazarini, J, Harp, CT, Ward, ES, Burgoon, M, Owens, GP, Racke, MK, Bennett, JL, Frohman, E & Monson, NL 2009, 'Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis', Journal of Neuroimmunology, vol. 213, no. 1-2, pp. 123-130. https://doi.org/10.1016/j.jneuroim.2009.05.014
Cameron, Elizabeth M. ; Spencer, Sade ; Lazarini, Jonathan ; Harp, Christopher T. ; Ward, E. Sally ; Burgoon, Mark ; Owens, Gregory P. ; Racke, Michael K. ; Bennett, Jeffrey L. ; Frohman, Elliot ; Monson, Nancy L. / Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis. In: Journal of Neuroimmunology. 2009 ; Vol. 213, No. 1-2. pp. 123-130.
@article{b73784b113374948b66606d82dcd18df,
title = "Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis",
abstract = "We identified a unique antibody gene mutation pattern (i.e. {"}signature{"}) in cerebrospinal fluid (CSF) B cells from multiple sclerosis (MS) patients not present in control populations. Prevalence of the signature in CSF B cells of patients at risk to develop MS predicted conversion to MS with 91{\%} accuracy in a small cohort of clinically isolated syndrome patients. If confirmed, signature prevalence would be a novel genetic diagnostic tool candidate for patients with early demyelinating disease of the central nervous system.",
keywords = "Antibodies, B lymphocytes, Gene rearrangement, Multiple sclerosis, Mutational signature",
author = "Cameron, {Elizabeth M.} and Sade Spencer and Jonathan Lazarini and Harp, {Christopher T.} and Ward, {E. Sally} and Mark Burgoon and Owens, {Gregory P.} and Racke, {Michael K.} and Bennett, {Jeffrey L.} and Elliot Frohman and Monson, {Nancy L}",
year = "2009",
month = "8",
day = "18",
doi = "10.1016/j.jneuroim.2009.05.014",
language = "English (US)",
volume = "213",
pages = "123--130",
journal = "Journal of Neuroimmunology",
issn = "0165-5728",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Potential of a unique antibody gene signature to predict conversion to clinically definite multiple sclerosis

AU - Cameron, Elizabeth M.

AU - Spencer, Sade

AU - Lazarini, Jonathan

AU - Harp, Christopher T.

AU - Ward, E. Sally

AU - Burgoon, Mark

AU - Owens, Gregory P.

AU - Racke, Michael K.

AU - Bennett, Jeffrey L.

AU - Frohman, Elliot

AU - Monson, Nancy L

PY - 2009/8/18

Y1 - 2009/8/18

N2 - We identified a unique antibody gene mutation pattern (i.e. "signature") in cerebrospinal fluid (CSF) B cells from multiple sclerosis (MS) patients not present in control populations. Prevalence of the signature in CSF B cells of patients at risk to develop MS predicted conversion to MS with 91% accuracy in a small cohort of clinically isolated syndrome patients. If confirmed, signature prevalence would be a novel genetic diagnostic tool candidate for patients with early demyelinating disease of the central nervous system.

AB - We identified a unique antibody gene mutation pattern (i.e. "signature") in cerebrospinal fluid (CSF) B cells from multiple sclerosis (MS) patients not present in control populations. Prevalence of the signature in CSF B cells of patients at risk to develop MS predicted conversion to MS with 91% accuracy in a small cohort of clinically isolated syndrome patients. If confirmed, signature prevalence would be a novel genetic diagnostic tool candidate for patients with early demyelinating disease of the central nervous system.

KW - Antibodies

KW - B lymphocytes

KW - Gene rearrangement

KW - Multiple sclerosis

KW - Mutational signature

UR - http://www.scopus.com/inward/record.url?scp=68049083540&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68049083540&partnerID=8YFLogxK

U2 - 10.1016/j.jneuroim.2009.05.014

DO - 10.1016/j.jneuroim.2009.05.014

M3 - Article

C2 - 19631394

AN - SCOPUS:68049083540

VL - 213

SP - 123

EP - 130

JO - Journal of Neuroimmunology

JF - Journal of Neuroimmunology

SN - 0165-5728

IS - 1-2

ER -